Melanoma Adjuvant Immunotherapy
Driving Improved Outcomes in Resectable Melanoma: Pathways for Optimized Adjuvant Immunotherapy Strategies

Released: November 30, 2023

Michael A. Davies
Michael A. Davies, MD, PhD
April Salama
April Salama, MD

Activity

Progress
1
Course Completed